Hanyu Medical focuses on the development of minimally invasive surgical catheters for structural heart disease. As transcatheter therapies for structural heart disease continue to advance, precision catheter technologies—particularly steerable catheters—have become critical to minimally invasive procedures. Since its founding, Hanyu Medical has developed a broad portfolio of products, including delivery systems for mitral and tricuspid valve repair devices and prosthetic valves, pulsed field ablation (PFA) systems, occluder delivery systems, transseptal puncture systems, and endoscopic catheters. The company has also established a manufacturing system compliant with ISO 13485 standards. Its catheter products have been adopted in clinical practice, enabling safer, less invasive, and more precise procedures for patients. Hanyu Medical also provides catheter design, R&D, and OEM manufacturing services
